LLY
Eli Lilly and Co
Price:  
807.43 
USD
Volume:  
1,773,906.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LLY EV/EBITDA

-73.5%
Upside

As of 2024-05-27, the EV/EBITDA ratio of Eli Lilly and Co (LLY) is 59.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LLY's latest enterprise value is 791,140.75 mil USD. LLY's TTM EBITDA according to its financial statements is 13,367.60 mil USD. Dividing these 2 quantities gives us the above LLY EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 7.6x - 21.6x 14.5x
Forward P/E multiples 20.2x - 25.7x 22.6x
Fair Price 82.19 - 286.30 214.37
Upside -89.8% - -64.5% -73.5%
807.43 USD
Stock Price
214.37 USD
Fair Price

LLY EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-24 59.18
2024-05-23 59.26
2024-05-22 58.86
2024-05-21 58.88
2024-05-20 57.46
2024-05-17 56.52
2024-05-16 56.60
2024-05-15 57.73
2024-05-14 56.09
2024-05-13 55.65
2024-05-10 55.81
2024-05-09 56.63
2024-05-08 56.88
2024-05-07 57.07
2024-05-06 56.29
2024-05-03 54.03
2024-05-02 55.52
2024-05-01 57.00
2024-04-30 57.31
2024-04-29 54.19
2024-04-26 53.93
2024-04-25 53.31
2024-04-24 53.83
2024-04-23 54.79
2024-04-22 53.77
2024-04-19 53.42
2024-04-18 54.81
2024-04-17 55.16
2024-04-16 54.87
2024-04-15 55.16
2024-04-12 55.22
2024-04-11 55.78
2024-04-10 55.95
2024-04-09 55.62
2024-04-08 57.04
2024-04-05 57.53
2024-04-04 56.39
2024-04-03 56.95
2024-04-02 56.09
2024-04-01 55.85
2024-03-28 57.09
2024-03-27 57.10
2024-03-26 56.87
2024-03-25 56.75
2024-03-22 56.57
2024-03-21 56.54
2024-03-20 56.73
2024-03-19 56.72
2024-03-18 56.00
2024-03-15 55.40